Central Trust CO Cytokinetics Inc Transaction History
Central Trust CO
- $4 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding CYTK
# of Institutions
397Shares Held
122MCall Options Held
3.57MPut Options Held
1.87M-
Black Rock Inc. New York, NY14.7MShares$677 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$550 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$496 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$364 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$285 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.35B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...